- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02660632
Epidural Block vs. Rectus Sheath Block on Postoperative Pulmonary Function
Effect of Thoracic Epidural Analgesia vs Rectus Sheath Catheters on Postoperative Pulmonary Function After Midline Laparotomy: A Prospective Randomized Controlled Study
Pulmonary complications are among the most important postoperative complications after midline incisions, for which different analgesic modalities have been tried.
Epidural analgesia is the recommended technique to relieve pain after major abdominal surgery owing to the proved superior analgesia, reduction of opioid related side effects as nausea, vomiting, pruritis and sedation, earlier recovery of bowel function and earlier ability for postoperative mobility However, it is not without complications.
Rectus sheath block provides several advantages over epidural anesthesia. It lessens the potential risks associated with neuraxial techniques, so it may represent a novel alternative approach for somatic analgesia after major abdominal surgeries. Although patients with rectus sheath block may experience some visceral pain, it is usually minimal by 24 hours after surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to compare the effects of thoracic epidural analgesia and rectus sheath blockade on postoperative pulmonary functions, pain scores, duration of analgesia, sedation scores, patients' satisfaction and adverse effects.
FEV1, FEV1/FVC ratio will be measured by a bed side spirometer.
- Induction of anesthesia: propofol 1.5-2.5 mg kg-1.
- Muscle Relaxants: rocuronium 0.6 mg kg-1 for induction.
- Maintenance: Sevoflurane 0.7-1.5 MAC vaporized in air-oxygen (40% inspired fraction).
Radial artery catheterization: under complete aseptic conditions 20G cannula will be inserted into the radial artery of non-dominant hand after performing modified Allen's test and local infiltration of 0.5ml xylocaine 2% .
Thoracic epidural catheter will be inserted before induction of general anaesthesia under aseptic insertion conditions and using loss of resistance to air technique with the patient in the sitting position at T9- T11 interspaces.
The Rectus sheath catheters will be inserted bilaterally using ultrasound (SonoSite M-Turbo®, Sonosite , USA) guidance as described by Webster after induction of general anaesthesia.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
DK
-
Mansourah, DK, Egypt, 050
- Mansoura University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- American Society of Anesthesiologists physical class I to III.
- Patients scheduled for elective midline laparotomy.
Exclusion Criteria:
- Morbid obese patients.
- Severe or uncompensated cardiovascular disease.
- Significant renal disease.
- Significant hepatic disease.
- Pregnancy.
- Lactating.
- Allergy to the study medications.
- Psychological disorder.
- Neurological disorder.
- Communication barrier.
- Mental disorders.
- Epilepsy.
- FEV1 or FEV1/FVC ratio less than 50%, dyspnea with a New York Heart Association class IV.
- Drug or alcohol abuse.
- Contraindications to epidural anaesthesia.
- Opioid analgesic medication within 24 h before the operation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Thoracic epidural analgesia (TEA)
Patients who will be subjected for midline laparotomy, will receive epidural analgesia through an inserted thoracic epidural catheter before induction of general anesthesia
|
Epidural catheter will be inserted at T9-T11.
Then, epidural analgesia will be activated with administering bolus of 10 mls 0.25% bupivacaine in conjunction with100 mcg fentanyl to establish a block.
This will be followed by an infusion of 0.125% bupivacaine in conjunction with 2 mcg/ ml fentanyl at a rate of 10 mls /hour and then titrated to effect for up to 48 hour postoperative
|
|
ACTIVE_COMPARATOR: Rectus sheath catheter block
After insertion of bilateral rectus sheath catheters, 20 ml of 0.25% bupivacaine will be injected on each side, then continuous infusion pumps will be connected to the catheters and set to deliver boluses of 20 mL of 0.25% bupivacaine, with a 4-hour lockout for up to 48 h postoperatively.
|
Following insertion of bilateral rectus sheath catheters, 20 ml of 0.25% bupivacaine will be injected through each one.
Then continuous infusion pumps will be connected to the catheters and set to deliver boluses of 20 mL of 0.25% bupivacaine, with a 4-hour lockout for up to 48 h postoperatively.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in forced expiratory volume in 1 second (FEV1)
Time Frame: Before and for 72 hours after surgery
|
Before and for 72 hours after surgery
|
|
Changes in ratio between forced expiratory volume in 1 s and forced vital capacity (FEV1/FVC)
Time Frame: Before and for 72 hours after surgery
|
Before and for 72 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in arterial blood gases
Time Frame: Before and for 72 hours after surgery
|
Before and for 72 hours after surgery
|
|
|
Visual analog pain scores
Time Frame: for 48 hours after surgery
|
Postoperative pain will be assessed on rest and with cough and during movements for both of visceral and parietal pain
|
for 48 hours after surgery
|
|
Sedation score
Time Frame: for 48 hours after surgery
|
Sedation scores using a sedation scale (awake and alert= 0; quietly awake= 1; asleep but easily roused= 2; deep sleep= 3.
|
for 48 hours after surgery
|
|
Postoperative nausea and vomiting
Time Frame: for 48 hours after surgery
|
The degree of nausea and vomiting.
Nausea will be measured using a numerical rating system (none= 0; mild= 1; moderate= 2; severe= 3).
The number of vomiting episodes and the number of anti-emetics received
|
for 48 hours after surgery
|
|
Return of bowel function
Time Frame: for 72 hours after surgery
|
The times to first flatus, defecation, intake of clear liquid and solid food tolerance
|
for 72 hours after surgery
|
|
Time to hospital discharge
Time Frame: for 15 days after surgery
|
from the end of anesthesia
|
for 15 days after surgery
|
|
Cumulative tramadol use
Time Frame: For 48 hours after surgery
|
For 48 hours after surgery
|
|
|
Overall patient's satisfaction
Time Frame: For 48 hours after surgery
|
Patient overall satisfaction will be assessed before hospital discharge using the visual analog score
|
For 48 hours after surgery
|
|
Intraoperative use of ephedrine
Time Frame: For 5 hours after induction of anesthesia
|
For 5 hours after induction of anesthesia
|
|
|
Postoperative cardio-respiratory complications
Time Frame: For 7 days after surgery
|
For 7 days after surgery
|
|
|
Postoperative wound infection
Time Frame: For 21 days after surgery
|
For 21 days after surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R ∕ 15.12.48
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Surgeries
-
TC Erciyes UniversityCompleted
-
South Valley UniversityCompletedMajor Abdominal SurgeriesEgypt
-
Assiut UniversityUnknownMajor Abdominal SurgeriesEgypt
-
Dolunay ARIKActive, not recruitingMajor Abdominal SurgeriesTurkey (Türkiye)
-
sarah mohamedActive, not recruitingDexmedetomidine | Dexamethasone | Abdominal SurgeriesEgypt
-
South Egypt Cancer InstituteNot yet recruiting
-
Assiut UniversityNot yet recruiting
-
Kocaeli UniversityKutahya Health Sciences University; Anadolu Medical CenterCompleted
-
National Cancer Institute, EgyptRecruitingPediatric Cancer | Nalbuphine | Abdominal Surgeries | TramadolEgypt
-
University Hospital DubravaRecruitingMechanical Ventilation | Major Abdominal SurgeriesCroatia
Clinical Trials on Thoracic epidural analgesia (TEA)
-
Nguyen Dang ThuVietnam National Children's HospitalCompletedPostoperative Pain | Thoracic Surgery Lung | Regional Anesthesia | Thoracotomy AnalgesiaVietnam
-
Karadeniz Technical UniversityRecruitingAnalgesia | Postoperative Analgesia | Chronic Postoperative Pain | Open Heart SurgeryTurkey (Türkiye)
-
South Egypt Cancer InstituteCompleted
-
M.D. Anderson Cancer CenterCompletedPancreatic Cancer | Liver CancerUnited States
-
Cairo UniversityCompletedShoulder Pain | Thoracic Cancer | Thoracotomy | Erector Spinae Plane BlockEgypt
-
Zagazig UniversityUnknownMid-line LaparotomiesEgypt
-
Seoul National University HospitalSeoul National UniversityCompleted
-
University Hospital FreiburgCompleted
-
Volgograd State Medical UniversityCompletedPost-ERCP Acute PancreatitisRussian Federation
-
Lawson Health Research InstituteCompleted